Cargando…
The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma
BACKGROUND: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis due to chemo-resistance and immuno-compromised micro-environment. The combination of zidovudine and interferon-alpha (IFN) significantly improved survival in ATL. Promising results were reported by adding a...
Autores principales: | Kchour, Ghada, Rezaee, SA Rahim, Farid, Reza, Ghantous, Akram, Rafatpanah, Houshang, Tarhini, Mahdi, Kooshyar, Mohamad-Mehdi, El Hajj, Hiba, Berry, Fadwa, Mortada, Mohamad, Nasser, Roudaina, Shirdel, Abbas, Dassouki, Zeina, Ezzedine, Mohamad, Rahimi, Hossein, Ghavamzadeh, Ardeshir, de Thé, Hugues, Hermine, Olivier, Mahmoudi, Mahmoud, Bazarbachi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751834/ https://www.ncbi.nlm.nih.gov/pubmed/23962110 http://dx.doi.org/10.1186/1742-4690-10-91 |
Ejemplares similares
-
The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma
por: Kchour, Ghada, et al.
Publicado: (2014) -
Animal models on HTLV-1 and related viruses: what did we learn?
por: Hajj, Hiba El, et al.
Publicado: (2012) -
Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation
por: Shirinian, Margret, et al.
Publicado: (2013) -
Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015) -
Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)